Lithospermic acid derivatives from Lithospermum erythrorhizon increased expression of serine palmitoyltransferase in human HaCaT cells

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 6, 2009, Pages 1815-1817

  Thuong, Phuong Thien ^a   Kang, Keon Wook ^a   Kim, Jeong Kee ^b   Seo, Dae Bang ^b   Lee, Sang Jun ^b   Kim, Sung Han ^c   Oh, Won Keun ^a  

^a Chosun University   (South Korea)

^b AmorePacific Corporation   (South Korea)

^c Nutrex Technology   (South Korea)

Author keywords

Lithospermic acid; Lithospermum erythrorhizon; Normal human keratinocyte cells (HaCaT cells); Serine palmitoyltransferase (SPT)

Indexed keywords

9' METHYLLITHOSPERMATE; LITHOSPERMIC ACID; LITHOSPERMUM ERYTHRORHIZON EXTRACT; MESSENGER RNA; NICOTINAMIDE; PLANT EXTRACT; SERINE PALMITOYLTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; LITHOSPERMUM; LITHOSPERMUM ERYTHRORHIZON; PERMEABILITY BARRIER; PLANT ROOT;

BENZOFURANS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DEPSIDES; DRUG DESIGN; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; KERATINOCYTES; LITHOSPERMUM; MODELS, CHEMICAL; NF-KAPPA B; PERMEABILITY; RNA, MESSENGER; SERINE C-PALMITOYLTRANSFERASE;

LITHOSPERMUM ERYTHRORHIZON;

EID: 61449218775     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.01.052     Document Type: Article

References (25)

1. Cho M.H., Paik Y.S., and Hahn T.R. J. Agric. Food Chem. 47 (1999) 4117
2. Staniforth V., Wang S.Y., Shyur L.F., and Yang N.S. J. Biol. Chem. 279 (2004) 5877
3. Yamamoto H., Inoue K., and Yazaki K. Phytochemistry 53 (2000) 651
4. Yamamoto H., Zhao P., Yazaki K., and Inoue K. Chem. Pharm. Bull. 50 (2002) 1086
5. Kim E.K., Kim E.Y., Moon P.D., Um J.Y., Kim H.M., Lee H.S., Sohn Y., Park S.K., Jung H.S., and Sohn N.W. Biosci. Biotechnol. Biochem. 71 (2007) 2886
6. Hou Y., Guo T., Wu C., He X., and Zhao M. Yakugaku Zhasshi 126 (2006) 1383
7. An S., Park Y.D., Paik Y.K., Jeong T.S., and Lee W.S. Bioorg. Med. Chem. Lett. 17 (2007) 1112
8. Kim J., Kim H., Jeong D.H., Kim S.H., Park S.K., and Cho Y. Biosci. Biotechnol. Biochem. 70 (2006) 2086
9. Chang M.J., Huang H.C., Chang H.C., and Chang T.M. Arch. Dermatol. Res. 300 (2008) 317
10. Ishida T., and Sakaguchi I. Biol. Pharm. Bull. 30 (2007) 928
11. Hanada K. Biochim. Biophys. Acta 1632 (2003) 16
12. Tanno O., Ota Y., Kitamura N., Katsube T., and Inoue S. Br. J. Dermatol. 143 (2000) 524
13. Imokawa G., Abe A., Jin K., Higaki Y., Kawashima M., and Hidano A. J. Invest. Dermatol. 96 (1991) 523
14. R = 42 min).
15. 13C NMR, see Table S1 (Supplementary data).
16. O'Malley S.J., Tan K.L., Watzke A., Bergman R.G., and Ellman J.A. J. Am. Chem. Soc. 127 (2005) 13496
17. Choudhary M.I., Begum A., Abbaskhan A., Ajaz A., and Shafique-ur-Rehman A.-u.-Rhaman. Chem. Pharm. Bull. 53 (2005) 1469
18. 2. Cells were harvested and analyzed 9 or 24 h after each treatment by reverse transcriptase-polymerase chain reaction (RT-PCR) or Western blot analysis. The cytotoxic activity of compounds against HaCaT cells was examined by a MTT method (Mosmann, T. J. Immunol. Method 1983, 65, 55).
19. 11 Statistical analysis. The statistical analyses were performed using the SPSS program (SPSS 12.0). One sample t-test was used to examine the difference between groups. p Values of 0.05 were considered to be statistically significant.
20. 12,13
21. NF-κB reporter gene assay. Cells were plated at in 12-well plate and transfected at 70% confluency. A dual-luciferase reporter assay system (Promega, Madison, WI) was used to determine promoter activity. Briefly, cells were transiently transfected with pNF-κB-luciferase plasmid and phRL-SV plasmid using the Hillymax reagent (Dojindo Molecular Technologies, Gaitherburg, MD). The cells were then incubated in culture medium without serum for 18 h. The firefly and hRenilla luciferase activities in the cell lysates were measured using a luminometer (LB941, Berthold Technologies, Bad Wildbad, Germany). The relative luciferase activity was calculated by normalizing the promoter-driven firefly luciferase activity to the hRenilla luciferase activity (Majumdar, S.; Lamothe, B.; Aggarwal, B. B. J. Immunol. 2002, 168, 2644).
22. Shimabukuro M., Higa M., Zhou Y.T., Wang M.Y., Wegard C.B., and Unger R.H. J. Biol. Chem. 273 (1998) 32487
23. Memon R.A., Holleran W.M., Moser A.H., Seki T., Uchida Y., Fuller J., Shigenaga J.K., Grunfeld C., and Feingold K.R. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1257
24. 22
25. Kim H.H., Lee Y., Eun H.C., and Chung J.H. Biochem. Biophys. Res. Commun. 368 (2008) 343